Squares are colored by quantitative undervaluation — tap any square for the full score breakdown. Scores computed 7/31/2026, 1:00:22 PM. Aristocrats Challenge →
Blend: 40% yield band + 35% sector dislocation + 25% safety. Green only when structurally cheap AND technically oversold.
Methodology: composite blends the stock's current TTM yield vs its own 3-year mean (40%), a beta-adjusted 30-day dislocation vs its SPDR sector ETF (35%), and free-cash-flow dividend coverage (25%). Dividends uncovered by FCF or yields stretched ≥2.5× their own history are hard-locked to trap red regardless of other scores. Scores refresh nightly.
Educational screen — not investment advice.
Disclaimer: The information provided on this website/service is for informational purposes only and does not constitute financial, investment, or legal advice. Investing in stocks involves high risk, including the loss of principal. We are not responsible for any financial losses or damages resulting from your reliance on this data. Always consult with a qualified financial professional before making investment decisions.
Trademark Notice: Twylight Crow's Dividend Tracker (formerly indexed as DiviDrip) is an independent portfolio utility. This tool is not affiliated with, authorized, endorsed by, or in any way officially connected to Dividrip.com or its international affiliates.
West Pharmaceutical Services, Inc. · Healthcare
Historically undervalued + oversold
Yield below its own 3-year mean
0.9σ OVERSOLD vs XLV over ~30 days (β 1.159)
Dividend covered by free cash flow
Yield 0.26% + 5-yr div CAGR 5.51%
Quantitative screen only — not investment advice.